Ranbaxy: STAT+: Sun Pharmaceuticals to pay $485 million to settle claims its Ranbaxy unit caused customers to overpay for generics

On the eve of a trial, Sun Pharmaceuticals has agreed to pay $485 million to settle lawsuits that alleged its Ranbaxy Pharmaceuticals unit misled regulators in order to win exclusive...